Tobacco industry's human rights makeover: an archival review of British American Tobacco's human rights rhetorical veneer.

Global health Human rights Tobacco industry Tobacco industry documents

Journal

Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612

Informations de publication

Date de publication:
13 12 2023
Historique:
received: 14 02 2022
accepted: 02 06 2022
medline: 28 12 2023
pubmed: 16 6 2022
entrez: 15 6 2022
Statut: epublish

Résumé

British American Tobacco (BAT) released an industry-first human rights report in 2020, which extolled the efforts and objectives of the tobacco industry giant for promoting human rights. How BAT came to brand itself as a human rights champion, being a leader in an industry long accused of enabling human rights violations from leaf-to-stub including profiting from a product which inherently violates the right to health, is unknown. Exploring BAT's evolution through reviewing its materials and Tobacco Industry Documents could shed light on their development and what it means in the tobacco control and human rights context. We reviewed publicly available materials from BAT as well as conducted archival research in the Tobacco Industry Documents digital archives at University of California San Francisco. We focused on how and when BAT used terms such as 'human rights', 'right to health', 'sustainable development goal' and 'harm reduction' as well as 'Framework Convention on Tobacco Control'. We reviewed 48 BAT publications and 45 documents from the Tobacco Industry Documents archives. These materials demonstrate both BAT's increasing utilisation of human rights language as well as BAT's reuse of the same language, concepts and general rhetoric. BAT has not engaged significantly or meaningfully on the human right to health. BAT's increasing use of human rights rhetoric does not appear to reflect a shift in the company's human rights positions, particularly with respect to the right to health of consumers and BAT's lack of impactful measures to eliminate the harms of its tobacco products.

Sections du résumé

BACKGROUND
British American Tobacco (BAT) released an industry-first human rights report in 2020, which extolled the efforts and objectives of the tobacco industry giant for promoting human rights. How BAT came to brand itself as a human rights champion, being a leader in an industry long accused of enabling human rights violations from leaf-to-stub including profiting from a product which inherently violates the right to health, is unknown. Exploring BAT's evolution through reviewing its materials and Tobacco Industry Documents could shed light on their development and what it means in the tobacco control and human rights context.
METHODOLOGY
We reviewed publicly available materials from BAT as well as conducted archival research in the Tobacco Industry Documents digital archives at University of California San Francisco. We focused on how and when BAT used terms such as 'human rights', 'right to health', 'sustainable development goal' and 'harm reduction' as well as 'Framework Convention on Tobacco Control'.
RESULTS
We reviewed 48 BAT publications and 45 documents from the Tobacco Industry Documents archives. These materials demonstrate both BAT's increasing utilisation of human rights language as well as BAT's reuse of the same language, concepts and general rhetoric. BAT has not engaged significantly or meaningfully on the human right to health.
CONCLUSION
BAT's increasing use of human rights rhetoric does not appear to reflect a shift in the company's human rights positions, particularly with respect to the right to health of consumers and BAT's lack of impactful measures to eliminate the harms of its tobacco products.

Identifiants

pubmed: 35705357
pii: tobaccocontrol-2022-057337
doi: 10.1136/tobaccocontrol-2022-057337
pmc: PMC9751230
mid: NIHMS1814804
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67-73

Subventions

Organisme : NCI NIH HHS
ID : R01 CA087472
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA113710
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA113710
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Tob Control. 2018 Jul;27(e1):e66-e69
pubmed: 29097589
Int J Health Policy Manag. 2018 Jan 23;7(7):677
pubmed: 29996591
Health Hum Rights. 2018 Dec;20(2):235-248
pubmed: 30568417
Tob Control. 2005 Aug;14 Suppl 2:ii14-8
pubmed: 16046696
BMC Public Health. 2021 Mar 4;21(1):439
pubmed: 33663456

Auteurs

Neiloy R Sircar (NR)

Public Health Law Center, Saint Paul, Minnesota, USA neil.sircar@mitchellhamline.edu.

Stella A Bialous (SA)

Center for Tobacco Control Research and Education, UCSF, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH